资讯
Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...
Ahmedabad: Intas Pharma has announced the appointment of Parthiv Mehta as the new Vice President - Rest of Africa & International Fertility. "We are delighted to welcome Parthiv Mehta as Vice ...
President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..
US President Donald Trump said that his administration would soon announce a “major" tariff on pharmaceutical imports. The levies will be aimed at encouraging drug manufacturers to shift operations ...
Trump also announced that the US will soon introduce “major tariff” on pharmaceuticals. Speaking at the Republican dinner, he said that the move will push pharmaceutical companies in China to ...
“We are going to be announcing very shortly a major tariff on pharmaceuticals,” President Donald Trump says at a National Republican Congressional Committee Dinner. Trump suggests that pharmaceutical ...
The drug modifies SMN2 gene splicing, improving motor neuron functionality. The plaintiffs, Roche, alleged that NATCO Pharma infringed their patent by initiating production of Risdiplam API (Active ...
Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...
President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the ...
Last Wednesday, when U.S. President Donald Trump unveiled a raft of duties on countries and industries he held back on hitting pharmaceuticals. He followed up on Tuesday by saying he would soon ...
April 9 (Reuters) - WW International (WW.O), opens new tab, also known as WeightWatchers, is preparing to file for bankruptcy in the coming months as part of a plan to hand control of the business ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果